NASDAQ: GNCA       Genocea Biosciences
Last Price Today's Change   Day's Range   Trading Volume
3.13   -0.13 (3.99%)  3.06 - 3.40  622,998


Avg Volume (4 weeks):646,982
4 Weeks Range:2.16 - 3.50
4 Weeks Price Volatility (%):
52 Weeks Range:1.10 - 5.75
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Genocea Biosciences Inc is a US-based biopharmaceutical company which is engaged in developing novel vaccines and immunotherapies to address diseases with significant unmet needs. Its product candidate includes GEN-003 which is an immunotherapy for the treatment of genital herpes as well as it owns pre-clinical immuno-oncology program focused on personalized cancer vaccines. The company focuses on developing vaccines and immunotherapies for unmet needs through its AnTigen Lead Acquisition System, which is used to design vaccines and immunotherapies. Genocea operates its business through the single segment being Developing and Commercializing vaccines.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

1978  4393  277  3253 

Top 10 Active Counters
 NAKD 0.491+0.055 
 F 11.65+0.79 
 ACST 0.848+0.092 
 BBIG 6.29+4.75 
 LK 1.38+1.38 
 CLSN 1.64+0.365 
 CTRM 0.352+0.027 
 WPX 9.43+0.48 
 ADTX 4.894+2.284 
 SNDL 0.657-0.023